TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results - Zacks Investment Research8 hours ago • Google News
TG Therapeutics stock holds Overweight rating at Cantor Fitzgerald - Investing.com3 hours ago • Google News
TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - MarketBeat4 hours ago • Google News